Allergan Partners with Assembly Bio to Gain Microbiome Gastrointestinal Development Programmes

By Natasha Piper

Pharma Deals Review: Vol 2017 Issue 3 (Table of Contents)

Published: 9 Mar-2017

DOI: 10.3833/pdr.v2017.i3.2230     ISSN: 1756-7874

Section: Licensing



In an effort to expand its gastroenterology therapeutic presence, Allergan has entered into a collaboration and licence agreement with Assembly Biosciences for the global rights to the latter’s microbiome gastrointestinal development programmes for a total deal value of up to US$2...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details